Fever News and Research

RSS
Natural killer T cells play important role in Lyme disease

Natural killer T cells play important role in Lyme disease

If cold symptoms persist it could be sinusitis

If cold symptoms persist it could be sinusitis

Blame your genes: why some people get sicker for longer

Blame your genes: why some people get sicker for longer

Genes influence how well you deal with an illness

Genes influence how well you deal with an illness

Breakthrough for dialysis patients

Breakthrough for dialysis patients

Peregrine Pharmaceuticals awarded U.S. patent for anti-viral applications of phospholipid-targeting antibodies

Peregrine Pharmaceuticals awarded U.S. patent for anti-viral applications of phospholipid-targeting antibodies

Call for greater caution in prescribing inhaled corticosteroids to COPD sufferers

Call for greater caution in prescribing inhaled corticosteroids to COPD sufferers

Researchers develop new strategy for broad spectrum anti-viral drugs

Researchers develop new strategy for broad spectrum anti-viral drugs

Discovery of new species of bacterium that causes leprosy

Discovery of new species of bacterium that causes leprosy

Discovery of new species of Ebola virus

Discovery of new species of Ebola virus

Common cold virus originated in birds

Common cold virus originated in birds

Human granulocytic anaplasmosis - tick-borne disease found in China

Human granulocytic anaplasmosis - tick-borne disease found in China

How household bleach kills bacteria

How household bleach kills bacteria

Strong relationship found between allergies and cancer in environmentally exposed tissues

Strong relationship found between allergies and cancer in environmentally exposed tissues

Airport malaria

Airport malaria

Latest research on diagnosis and treatment of allergic diseases

Latest research on diagnosis and treatment of allergic diseases

The smaller the mozzie the nastier the bite

The smaller the mozzie the nastier the bite

VIA Pharmaceuticals announces results of phase 2 trials of VIA-2291 in cardiovascular disease

VIA Pharmaceuticals announces results of phase 2 trials of VIA-2291 in cardiovascular disease

Crestor (rosuvastatin calcium) shown to significantly reduce major cardiovascular events

Crestor (rosuvastatin calcium) shown to significantly reduce major cardiovascular events

Advances in ophthalmology

Advances in ophthalmology

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.